Literature DB >> 21643008

Pdcd4 directly binds the coding region of c-myb mRNA and suppresses its translation.

P Singh1, L Wedeken, L C Waters, M D Carr, K-H Klempnauer.   

Abstract

Pdcd4 is a novel tumor suppressor protein that functions in the nucleus and the cytoplasm, and appears to be involved in the regulation of transcription and translation. In the cytoplasm, Pdcd4 has been implicated in the suppression of translation of mRNAs containing structured 5'-untranslated regions; however, the mechanisms that recruit Pdcd4 to specific target mRNAs and the identities of these mRNAs are mostly unknown. In this study, we have identified c-myb mRNA as the first natural translational target mRNA of Pdcd4. We have found that translational suppression of c-myb mRNA by Pdcd4 is dependent on sequences located within the c-myb-coding region. Furthermore, we have found that the N-terminal domain of Pdcd4 has an important role in targeting Pdcd4 to c-myb RNA by mediating preferential RNA binding to the Pdcd4-responsive region of c-myb mRNA. Overall, our work demonstrates for the first time that Pdcd4 is directly involved in translational suppression of a natural mRNA and provides the first evidence for a key role of the RNA-binding domain in targeting Pdcd4 to a specific mRNA.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21643008     DOI: 10.1038/onc.2011.202

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  26 in total

1.  Tumor suppressor PDCD4 represses internal ribosome entry site-mediated translation of antiapoptotic proteins and is regulated by S6 kinase 2.

Authors:  Urszula Liwak; Nehal Thakor; Lindsay E Jordan; Rajat Roy; Stephen M Lewis; Olivier E Pardo; Michael Seckl; Martin Holcik
Journal:  Mol Cell Biol       Date:  2012-03-19       Impact factor: 4.272

2.  Tumor suppressor PDCD4 inhibits NF-κB-dependent transcription in human glioblastoma cells by direct interaction with p65.

Authors:  Soon-Kyung Hwang; Alyson R Baker; Matthew R Young; Nancy H Colburn
Journal:  Carcinogenesis       Date:  2014-01-11       Impact factor: 4.944

3.  Tumor suppressor protein Pdcd4 inhibits translation of p53 mRNA.

Authors:  Lena Wedeken; Priyanka Singh; Karl-Heinz Klempnauer
Journal:  J Biol Chem       Date:  2011-10-27       Impact factor: 5.157

4.  Role of programmed cell death 4 in diseases: a double-edged sword.

Authors:  Yang Jiang; Yufeng Jia; Lining Zhang
Journal:  Cell Mol Immunol       Date:  2017-09-18       Impact factor: 11.530

Review 5.  The role of Pdcd4 in tumour suppression and protein translation.

Authors:  Qing Wang; Hsin-Sheng Yang
Journal:  Biol Cell       Date:  2018-05-28       Impact factor: 4.458

6.  Cytoplasmic localization of programmed cell death 4 contributes to its anti-apoptotic function.

Authors:  Syohei Takaki; Ko Eto
Journal:  Mol Cell Biochem       Date:  2018-02-13       Impact factor: 3.396

7.  Deficiency of programmed cell death 4 results in increased IL-10 expression by macrophages and thereby attenuates atherosclerosis in hyperlipidemic mice.

Authors:  Yang Jiang; Qi Gao; Liyang Wang; Chun Guo; Faliang Zhu; Bo Wang; Qun Wang; Fei Gao; Youhai Chen; Lining Zhang
Journal:  Cell Mol Immunol       Date:  2015-07-13       Impact factor: 11.530

8.  Programmed cell death 4 and BCR-ABL fusion gene expression are negatively correlated in chronic myeloid leukemia.

Authors:  Xia Zhang; Riming Liu; Baohua Huang; Xiaolu Zhang; Weijuan Yu; Cuixia Bao; Jie Li; Chengming Sun
Journal:  Oncol Lett       Date:  2016-08-03       Impact factor: 2.967

9.  Tumor suppressor gene PDCD4 negatively regulates autophagy by inhibiting the expression of autophagy-related gene ATG5.

Authors:  Xingguo Song; Xia Zhang; Xiaoyan Wang; Faliang Zhu; Chun Guo; Qun Wang; Yongyu Shi; Jianing Wang; Youhai Chen; Lining Zhang
Journal:  Autophagy       Date:  2013-03-13       Impact factor: 16.016

10.  Programmed cell death 4 mechanism of action: The model to be updated?

Authors:  Polina N Vikhreva; Svetlana V Kalinichenko; Igor V Korobko
Journal:  Cell Cycle       Date:  2017-08-30       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.